Friedreich's ataxia is the most common genetic ataxia, autosomal recessive
Pathophysiology: tri-nucleotide repeat disorder
Presentation: 5-25yrs; ataxia, loss of LL distal power & sensation, reduced visual acuity or hearing
Diagnosis: genetic testing
Incidence: 1/40,000, most commonly Caucasians
Accounts for 50% of all ataxia, 75% under 25yrs
Trinucleotide repeats affect frataxin (FXN) gene on chromosone 9
Complications: heart failure & diabetes
Cause of death: hypertrophic cardiomopathy
History
5-25yrs caucasion
Poor mobility
Visual/ hearing issues
Examination
Ataxia
Reduced lower limb power, sensation & reflexes
Investigations
Genetic testing: diagnostic- GAA repeats
MRI of brain & spinal chord will show atrophy
ECG: atrial fibrillation
Diagnostic criteria: genetic testing (FXN gene)
Monitor mobility, heart, hearing and vision
Physio, mobility, orthotics
Medical mx of CHF, analgesia, infection prophylaxis
Complications
Death most commonly occurs from cardiac arrhythmias
Prognosis
Age of diagnosis usually < 20 years
Loss of ability to walk 15yrs post diagnosis
Life expectancy 40-50yrs
Williams CT, De Jesus O. Friedreich Ataxia. [Updated 2023 Aug 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563199/
Written 2025.